Skip to main content
Clinical Trials/NCT03243448
NCT03243448
Enrolling by Invitation
N/A

Using Skin Sympathetic Nerve Activity to Estimate Sympathetic Tone in Human

Kaohsiung Medical University Chung-Ho Memorial Hospital0 sites1,000 target enrollmentAugust 1, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Nerve; Disorder, Sympathetic
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Enrollment
1000
Primary Endpoint
Skin Sympathetic Nerve Activity
Status
Enrolling by Invitation
Last Updated
2 years ago

Overview

Brief Summary

There are many sympathetic hyperactivity diseases in the investigators' clinical practice. However, the conventional method to measure the sympathetic nerve activity had many limitations such as clinical application, data interpretation and even therapeutic manipulation. Therefore the investigators would like to develop a non-invasive method to record the sympathetic nerve activity in the investigators' study that can help gathering the sympathetic nerve activity easily in the investigators' daily clinical situation. By the determination of sympathetic nerve activity status, the health caregiver can understand the disease more.

Registry
clinicaltrials.gov
Start Date
August 1, 2016
End Date
July 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Sympathetic hyperactivity diseases included: hypertension, heart failure atherosclerotic diseases, arrhythmias, cardiomyopathy, pulmonary hypertension, chronic obstructive pulmonary disease, sleep apnea, pulmonary embolism, hepatitis, liver cirrhosis, hepatopulmonary syndrome, hepatorenal syndrome, renal failure, nephritis, irritable bowel syndrome.
  • Healthy Volunteers

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Skin Sympathetic Nerve Activity

Time Frame: 12 hours

The Sympathetic Nerve Activity Recording from the skin of the subjects in the day time.

Secondary Outcomes

  • ventricular arrhythmia(24 to 72 hours)
  • Mortality(1 to 12 months)
  • Morbidity(1 to 12 months)

Similar Trials